SynAct Pharma AB (SYNACT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.000x

Based on the latest financial reports, SynAct Pharma AB (SYNACT) has a cash flow conversion efficiency ratio of 0.000x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-18.79K ≈ $-2.02K USD) by net assets (Skr196.41 Million ≈ $21.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SynAct Pharma AB - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how SynAct Pharma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SynAct Pharma AB debt and liabilities for a breakdown of total debt and financial obligations.

SynAct Pharma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SynAct Pharma AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mobiletron Electronics Co Ltd TW:1533	0.018x
Shanghai Huili Building Materials Co Ltd SHG:900939	-0.016x
Kestrel Group, Ltd. NYSE:KG	-0.023x
Vascon Engineers Limited NSE:VASCONEQ	-0.065x
Vranken-Pommery Monopole Société Anonyme PA:VRAP	-0.107x
CLERHP Estructuras S.A MC:CLR	-0.061x
Caravel Minerals Ltd AU:CVV	-0.375x
MEI Pharma Inc NASDAQ:MEIP	-0.145x

Annual Cash Flow Conversion Efficiency for SynAct Pharma AB (2016–2024)

The table below shows the annual cash flow conversion efficiency of SynAct Pharma AB from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see SYNACT stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr214.17 Million ≈ $23.05 Million	Skr-89.20 Million ≈ $-9.60 Million	-0.416x	+26.75%
2023-12-31	Skr176.19 Million ≈ $18.96 Million	Skr-100.18 Million ≈ $-10.78 Million	-0.569x	+38.81%
2022-12-31	Skr126.52 Million ≈ $13.62 Million	Skr-117.56 Million ≈ $-12.65 Million	-0.929x	+70.17%
2021-12-31	Skr20.87 Million ≈ $2.25 Million	Skr-65.00 Million ≈ $-6.99 Million	-3.115x	-48.68%
2020-12-31	Skr15.87 Million ≈ $1.71 Million	Skr-33.24 Million ≈ $-3.58 Million	-2.095x	-75.44%
2019-12-31	Skr13.50 Million ≈ $1.45 Million	Skr-16.12 Million ≈ $-1.74 Million	-1.194x	+49.15%
2018-12-31	Skr10.31 Million ≈ $1.11 Million	Skr-24.21 Million ≈ $-2.61 Million	-2.348x	-76.25%
2017-12-31	Skr12.91 Million ≈ $1.39 Million	Skr-17.20 Million ≈ $-1.85 Million	-1.332x	-144.84%
2016-12-31	Skr27.08 Million ≈ $2.91 Million	Skr-14.73 Million ≈ $-1.59 Million	-0.544x	--

About SynAct Pharma AB

ST:SYNACT Sweden Biotechnology

Market Cap

$100.89 Million

Skr937.55 Million SEK

Market Cap Rank

#19155 Global

#340 in Sweden

Share Price

Skr17.58

Change (1 day)

+0.11%

52-Week Range

Skr13.98 - Skr24.95

All Time High

Skr143.40